Hemato-1-1-spleen_Hemato-spleen (1-45)_Rx_13M_HE_traumatic splenic laceration with normal spleen

Hemato-1-2-spleen_Hemato-spleen (1-45)_Rx_50F_HE/macro_spontaneous splenic rupture caused by cavernous hemangioma

Hemato-2-spleen_Hemato-spleen (1-45)_Rx_27F_HE_accessory spleen

Hemato-3-1-spleen_Hemato-spleen (1-45)_Rx_3yr11moF_HE_Gaucher’s disease-1

Hemato-3-2-spleen_Hemato-spleen (1-45)_Rx_30'sM/40'sM_HE_Gaucher’s disease-2

Hemato-4-spleen_Hemato-spleen (1-45)_Au_30'sF_HE_onion-skin lesion in SLE

Hemato-5-spleen_Hemato-spleen (1-45)_Au_1dayM_HE_acute congestion in ornithine transcarbamylase deficiency

Hemato-6-spleen_Hemato-spleen (1-45)_Rx_54F_HE_chronic passive congestion

Hemato-7-1-spleen_Hemato-spleen (1-45)_Au_adultM_HE_extramedullary hematopoiesis

Hemato-7-2-spleen_Hemato-spleen (1-45)_Au_adults_HE/IHC_extramedullary hematopoiesis in the spleen

Hemato-8-1-spleen_Hemato-spleen (1-45)_Au_85F_HE_hidden functions of the spleen-1

Hemato-8-2-spleen_Hemato-spleen (1-45)_Au_85F_IHC (CD61)_hidden functions of the spleen-2

Hemato-8-3-spleen_Hemato-spleen (1-45)_Rx_54F_IHC (CD61)_hidden functions of the spleen-3

Hemato-9-1-spleen_Hemato-spleen (1-45)_Au_88F_HE_splenic infarction, embolic-type

Hemato-9-2-spleen_Hemato-spleen (1-45)_Au_33M_HE_splenic infarction due to splenic vein thrombosis

Hemato-10-1-spleen_Hemato-spleen (1-45)_Au_88F_HE_hemosiderosis with splenic infarction-1

Hemato-10-2-spleen_Hemato-spleen (1-45)_Au_88F_Berlin blue_hemosiderosis with splenic infarction-2

Hemato-11-spleen_Hemato-spleen (1-45)_Au_57M_HE_Gamna-Gandy nodules with splenic infarction

Hemato-12-spleen_Hemato-spleen (1-45)_Au_82F_HE_sugar-coated spleen

Hemato-13-spleen_Hemato-spleen (1-45)_Au_74F_HE_acute splenitis

Hemato-14-spleen_Hemato-spleen (1-45)_Au_56M_HE_multiple fibrin thrombi in the red pulp

Hemato-15-spleen_Hemato-spleen (1-45)_Rx_13M_HE_hereditary spherocytosis

Hemato-16-spleen_Hemato-spleen (1-45)_Rx_9F_HE_idiopathic thrombocytopenic purpura in an accessory spleen

Hemato-17-1-spleen_Hemato-spleen (1-45)_Au_82M_HE_AA amyloidosis with SAA production in pancreatic acinar cells-1

Hemato-17-2-spleen_Hemato-spleen (1-45)_Au_82M_IHC (amyloid A)_AA amyloidosis with SAA production in pancreatic acinar cells-2

Hemato-18-1-spleen_Hemato-spleen (1-45)_Au_37M_HE_lepromas in internal organs in lepromatous leprosy-1

Hemato-18-2-spleen_Hemato-spleen (1-45)_Au_37M_IHC (BCG)_lepromas in internal organs in lepromatous leprosy-2

Hemato-19-spleen_Hemato-spleen (1-45)_Rx_adultM_HE_melioidosis

Hemato-20-1-spleen_Hemato-spleen (1-45)_Rx_12F_HE_cat scratch disease (splenic suppurative granuloma)-1

Hemato-20-2-spleen_Hemato-spleen (1-45)_Rx_12F_IHC (B. henselae)_cat scratch disease (splenic suppurative granuloma)-2

Hemato-20-3-spleen_Hemato-spleen (1-45)_Bx_12F_HE (skin biopsy)_cat scratch disease (splenic suppurative granuloma)-3 (the site of cat scratch)

Hemato-21-1-spleen_Hemato-spleen (1-45)_Au_68F_HE_Japanese spotted fever (splenic granuloma)-1

Hemato-21-2-spleen_Hemato-spleen (1-45)_Au_68F_IHC (R. japonica-S3)_Japanese spotted fever (splenic granuloma)-2

Hemato-22-spleen_Hemato-spleen (1-45)_Au_60'sM_HE_splenic candidosis with gas production

Hemato-23-spleen_Hemato-spleen (1-45)_Au_2F_HE_splenic mucormycosis

Hemato-24-spleen_Hemato-spleen (1-45)_Au_30'sF_HE_splenic penicilliosis marneffei

Hemato-25-1-spleen_Hemato-spleen (1-45)_Au_70F_HE_systemic varicella-zoster virus infection-1

Hemato-25-2-spleen_Hemato-spleen (1-45)_Au_70F_IHC (VZV-Ag: GP1)_systemic varicella-zoster virus infection-2

Hemato-26-1-spleen_Hemato-spleen (1-45)_Au_57M_HE (spleen)_CMV hepatitis in a case of malignant lymphoma after chemotherapy-1

Hemato-26-2-spleen_Hemato-spleen (1-45)_Au_57M_HE (liver)_CMV hepatitis in a case of malignant lymphoma after chemotherapy-2

Hemato-27-1-spleen_Hemato-spleen (1-45)_Au_46M_HE_EBV-associated hemophagocytic syndrome (EB-VAHS)-1

Hemato-27-2-spleen_Hemato-spleen (1-45)_Au_46M_ISH (EBER)_EBV-associated hemophagocytic syndrome (EB-VAHS)-2

Hemato-28-1-spleen_Hemato-spleen (1-45)_Au_85F_HE_severe fever thrombocytopenia syndrome (SFTS)-1

Hemato-28-2-spleen_Hemato-spleen (1-45)_Au_85F_IHC (SFTSV-Ag), 1C3_severe fever thrombocytopenia syndrome (SFTS)-2

Hemato-29-1-spleen_Hemato-spleen (1-45)_Au_67M_HE (spleen)_malaria falciparum (malignant malaria)-1

Hemato-29-2-spleen_Hemato-spleen (1-45)_Au_67M_HE (liver)_malaria falciparum (malignant malaria)-2

Hemato-29-3-spleen_Hemato-spleen (1-45)_Au_67M_HE (brain)_malaria falciparum (malignant malaria)-3

Hemato-30-spleen_Hemato-spleen (1-45)_Rx_65M_HE_Ascaris larva migration

Hemato-31-spleen_Hemato-spleen (1-45)_Rx_26F_HE_splenic epidermoid cyst

Hemato-32-spleen_Hemato-spleen (1-45)_Rx_57F_HE_splenoma (splenic hamartoma)

Hemato-33-spleen_Hemato-spleen (1-45)_Rx_32F_HE_littoral cell angioma

Hemato-34-spleen_Hemato-spleen (1-45)_Rx_53F_HE/macro_splenic lymphangioma

Hemato-35-1-spleen_Hemato-spleen (1-45)_Rx_25M_HE_IGF2-producing hemangioendothelioma-1

Hemato-35-2-spleen_Hemato-spleen (1-45)_Rx_25M_IHC (CD34)_IGF2-producing hemangioendothelioma-2

Hemato-36-spleen_Hemato-spleen (1-45)_Rx_66F_HE_splenic inflammatory pseudotumor

Hemato-37-spleen_Hemato-spleen (1-45)_Rx_23M_HE_chronic myeloid leukemia

Hemato-38-1-spleen_Hemato-spleen (1-45)_Rx_66M_HE_hairy cell leukemia

Hemato-38-2-spleen_Hemato-spleen (1-45)_Rx_80F_HE/EM_splenic diffuse red pulp small B-cell lymphoma

Hemato-39-1-spleen_Hemato-spleen (1-45)_Au_68M_HE_EBV-related polyclonal LPD of lymphoplasmacytic type

Hemato-39-2-spleen_Hemato-spleen (1-45)_Au_68M_ISH (EBER)_EBV-related polyclonal LPD of lymphoplasmacytic type

Hemato-39-3-spleen_Hemato-spleen (1-45)_Au_68M_IHC (Ki-67)_EBV-related polyclonal LPD of lymphoplasmacytic type

Hemato-40-spleen_Hemato-spleen (1-45)_Rx_33M_HE_splenic marginal zone lymphoma

Hemato-41-spleen_Hemato-spleen (1-45)_Rx_44M_HE_splenic follicular lymphoma

Hemato-42-1-spleen_Hemato-spleen (1-45)_Rx_30'sM_HE_hepatosplenic CD8+ T-cell lymphoma-1

Hemato-42-2-spleen_Hemato-spleen (1-45)_Rx_30'sM_IHC (CD8)_hepatosplenic CD8+ T-cell lymphoma-2

Hemato-42-3-spleen_Hemato-spleen (1-45)_Rx_30'sM_IHC (granzyme B)_hepatosplenic CD8+ T-cell lymphoma-3

Hemato-43-1-spleen_Hemato-spleen (1-45)_Rx_58M_HE_lymphoma-associated hemophagocytic lymphohistiocytosis-1

Hemato-43-2-spleen_Hemato-spleen (1-45)_Rx_55F_HE/Giemsa/EM/macro_lymphoma-associated hemophagocytic lymphohistiocytosis-2

Hemato-44-spleen_Hemato-spleen (1-45)_Au_adult_HE/macro_splenic Hodgkin lymphoma

Hemato-45-spleen_Hemato-spleen (1-45)_Rx_71M_HE_splenic metastasis of lung squamous cell carcinoma

Hemato-46-1-BM_Hemato-BM (46-91)_PB_-_Giemsa_erythrocyte variations in May-Giemsa-stained smears

Hemato-46-2-BM_Hemato-BM (46-91)_PB_-_Giemsa_leukocyte variations in May-Giemsa-stained smears

Hemato-46-3-BM_Hemato-BM (46-92)_PB_-_Giemsa_thrombocyte variations in May-Giemsa-stained smears

Hemato-47-BM_Hemato-BM (46-92)_PB/BM_-_EM_electron micrographs of hematopoietic cells and their neoplasms

Hemato-48-1-BM_Hemato-BM (46-92)_Asp_77F_HE_serous atrophy of bone marrow (starvation marrow)-1

Hemato-48-2-BM_Hemato-BM (46-92)_Asp_77F_HE/Giemsa_serous atrophy of bone marrow (starvation marrow)-2

Hemato-49-BM_Hemato-BM (46-92)_Asp_1M_Giemsa_contamination of rods in a bone marrow specimen of idiopathic thrombocytopenic purpura

Hemato-50-BM_Hemato-BM (46-92)_Bx_3yr11moF_HE_Gaucher's disease

Hemato-51-BM_Hemato-BM (46-92)_Bx_-_Giemsa/HE_Niemann-Pick’s disease, type C (BM/liver/spleen)

Hemato-52-BM_Hemato-BM (46-92)_Asp_49M_HE_miliary tuberculosis

Hemato-53-1-BM_Hemato-BM (46-92)_Bx_72M_HE_striated histiocytes in Mycobacterium avium-intracellulare infection after steroid administration-1

Hemato-53-2-BM_Hemato-BM (46-92)_Bx_72M_Ziehl-Neelsen_striated histiocytes in Mycobacterium avium-intracellulare infection after steroid administration-2

Hemato-53-3-BM_Hemato-BM (46-92)_Bx_72M_Grocott_striated histiocytes in Mycobacterium avium-intracellulare infection after steroid administration-3

Hemato-53-4-BM_Hemato-BM (46-92)_Bx_72M_IHC (BCG)_striated histiocytes in Mycobacterium avium-intracellulare infection after steroid administration-4

Hemato-54-1-BM_Hemato-BM (46-92)_Bx_54F_HE_Toxoplasma osteomyelitis after cord blood cell transplantation for ALL-1

Hemato-54-2-BM_Hemato-BM (46-92)_Bx_54F_IHC (T. gondii)_Toxoplasma osteomyelitis after cord blood cell transplantation for ALL-2

Hemato-55-BM_Hemato-BM (46-92)_Bx_77M_HE_polyclonal plasmacytosis

Hemato-56-1-BM_Hemato-BM (46-92)_Asp_56F_HE_myeloid hyperplasia, S/P: G-CSF administration

Hemato-56-2-BM_Hemato-BM (46-92)_Asp/Bx_73M_HE/Giemsa/IHC_reactive shift to left (pseudo-promyelocytic leukemia) after G-CSF administration

Hemato-57-1-BM_Hemato-BM (46-92)_Asp_35F_HE_idiopathic thrombocytopenic purpura-1

Hemato-57-2-BM_Hemato-BM (46-92)_Bx_35F_HE_idiopathic thrombocytopenic purpura-2

Hemato-58-1-BM_Hemato-BM (46-92)_Asp_25F_HE_hypereosinophilic syndrome

Hemato-58-2-BM_Hemato-BM (46-92)_Asp_41F_HE_eosinophilia in Churg-Strauss syndrome

Hemato-59-1-BM_Hemato-BM (46-92)_Bx_33M_HE_pure red cell aplasia provoked after erythema infectiosum (parvovirus B19 infection)-1

Hemato-59-2-BM_Hemato-BM (46-92)_Bx_33M_IHC (Parvo B19)_pure red cell aplasia provoked after erythema infectiosum (parvovirus B19 infection)-2

Hemato-60-1-BM_Hemato-BM (46-92)_Asp_26F_HE_autoimmune hemolytic anemia (erythroid hyperplasia)-1

Hemato-60-2-BM_Hemato-BM (46-92)_Bx_26F_HE_autoimmune hemolytic anemia (erythroid hyperplasia)-2

Hemato-61-1-BM_Hemato-BM (46-92)_Asp_86F_HE_aplastic anemia-1

Hemato-61-2-BM_Hemato-BM (46-92)_Bx/Asp_40'sM/50'sF/50'sM_Giemsa/HE_aplastic anemia-2

Hemato-61-a-BM_Hemato-BM (46-92)_Au_19M_TB/EM_lactic acidosis seen after bone marrow transplantation for aplastic anemia

Hemato-62-1-BM_Hemato-BM (46-92)_Asp_82F_HE_megaloblastic anemia-1

Hemato-62-2-BM_Hemato-BM (46-92)_Asp_82F_IHC (HbF)_megaloblastic anemia-2

Hemato-63-BM_Hemato-BM (46-92)_Asp_68M_HE_Ara-C induced megaloblastic change

Hemato-64-1-BM_Hemato-BM (46-92)_Asp_25M_HE_hemophagocytic syndrome-1

Hemato-64-2-BM_Hemato-BM (46-92)_Asp_25M_IHC (CD68)_hemophagocytic syndrome-2

Hemato-65-1-1-BM_Hemato-BM (46-92)_Asp_82M_HE_sideroblastic anemia (myelodysplastic syndrome)-1

Hemato-65-1-2-BM_Hemato-BM (46-92)_Asp_82M_Berlin blue_sideroblastic anemia (myelodysplastic syndrome)-2

Hemato-65-2-BM_Hemato-BM (46-92)_Bx_74M_HE_myelodysplastic syndrome (MDS) with reticulin fibrosis

Hemato-65-3-BM_Hemato-BM (46-92)_Asp_60F_HE_MDS with hypocellularity

Hemato-65-4-BM_Hemato-BM (46-92)_Asp_91F_HE_MDS with megakaryocytic growth

Hemato-65-5-BM_Hemato-BM (46-92)_Asp_71M_HE_MDS with increased blasts (refractory anemia with excess blasts)

Hemato-65-6-1-BM_Hemato-BM (46-92)_Bx_81M_HE_MDS with panmyelosis and reticulin fibrosis-1

Hemato-65-6-2-BM_Hemato-BM (46-92)_Bx_81M_silver_MDS with panmyelosis and reticulin fibrosis-2

Hemato-65-7-BM_Hemato-BM (46-92)_Asp_64M_HE_MDS with large cell growth

Hemato-65-8-BM_Hemato-BM (46-92)_Asp/Bx_57M_HE/Giemsa/silver/IHC/EM_chronic myelomonocytic leukemia, myelodysplastic type

Hemato-66-1-BM_Hemato-BM (46-92)_Asp_60'sM_HE/Giemsa/EM_AML (M0)

Hemato-66-2-BM_Hemato-BM (46-92)_Asp_83M_HE_AML (M1)

Hemato-66-3-BM_Hemato-BM (46-92)_Asp_33F_HE_AML (M2)

Hemato-66-4-BM_Hemato-BM (46-92)_BM_60M_HE_AML (M2) with eosinophilia

Hemato-66-5-BM_Hemato-BM (46-92)_Asp_64F_HE_APL (M3) with a few faggot cells

Hemato-66-6-1-BM_Hemato-BM (46-92)_Asp_34M_HE_APL (M3) with numerous faggot cells

Hemato-66-6-2-BM_Hemato-BM (46-92)_Asp_34M_HE_APL (M3), 23 days after ATRA therapy

Hemato-66-7-BM_Hemato-BM (46-92)_Asp_55F_HE_AMMoL (M4) with monocytoid appearance

Hemato-66-8-BM_Hemato-BM (46-92)_Asp_48M_HE_AMMoL (M4) with epithelioid appearance

Hemato-66-8-a-BM_Hemato-BM (46-92)_Au_56M_HE/Giemsa/IHC/macro_multiple brain hemorrhage in acute myelomonocytic leukemia

Hemato-66-9-BM_Hemato-BM (46-92)_Asp_48F_HE_AMoL (M5b)

Hemato-66-10-BM_Hemato-BM (46-92)_Asp_68M_HE_AMoL (M5) with eosinophilia

Hemato-66-11-BM_Hemato-BM (46-92)_Asp_73M_HE_erythroleukemia (M6)

Hemato-66-11-a-BM_Hemato-BM (46-92)_Asp_59M_HE_acute myeloid leukemia, M6/M7, with cytoplasmic vacuoles

Hemato-66-12-1-BM_Hemato-BM (46-92)_Au_85M_HE (BM)_AML with both myeloblastic and megakaryocytic growth-1

Hemato-66-12-2-BM_Hemato-BM (46-92)_Au_85M_HE (LN)_AML with both myeloblastic and megakaryocytic growth-2

Hemato-67-BM_Hemato-BM (46-92)_Asp_-_Giemsa/Pox/Berline blue_acute myeloid leukemias in May-Giemsa smears

Hemato-68-1-1-BM_Hemato-BM (46-92)_Asp_60M_HE_B-ALL-1-1

Hemato-68-1-2-BM_Hemato-BM (46-92)_Asp_60M_IHC (CD34)_B-ALL-1-2

Hemato-68-2-1-BM_Hemato-BM (46-92)_Bx_10'sM_HE_B-ALL-2-1

Hemato-68-2-2-BM_Hemato-BM (46-92)_Bx_10'sM_IHC (CD10)_B-ALL-2-2

Hemato-69-1-BM_Hemato-BM (46-92)_Asp_55M_HE_B-CLL-1

Hemato-69-2-1-BM_Hemato-BM (46-92)_Bx_45F_HE_B-CLL, sIgM (lambda)-2-1

Hemato-69-2-2-BM_Hemato-BM (46-92)_Bx_45F_IHC (IgM)_B-CLL, sIgM (lambda)-2-2

Hemato-70-1-BM_Hemato-BM (46-92)_PB (buffy coat)_74F_HE_hairy cell leukemia-1

Hemato-70-2-BM_Hemato-BM (46-92)_Bx_52M_HE_hairy cell leukemia-2

Hemato-71-BM_Hemato-BM (46-92)_Asp_65F_HE_T-cell prolymphocytic leukemia

Hemato-71-a-BM_Hemato-BM (46-92)_Asp_70'sF_HE/Giemsa/EM_large granular lymphocytic (LGL) leukemia

Hemato-72-1-1-BM_Hemato-BM (46-92)_Asp_57F_HE_adult T-cell leukemia-1

Hemato-72-1-2-BM_Hemato-BM (46-92)_CSF_57F_Giemsa_adult T-cell leukemia-2

Hemato-72-2-BM_Hemato-BM (46-92)_Asp_71M_HE_adult T-cell leukemia-associated hemophagocytic lymphohistiocytosis

Hemato-73-BM_Hemato-BM (46-92)_Asp_-_Giemsa_lymphoid leukemias and multiple myeloma in May-Giemsa smears

Hemato-74-1-BM_Hemato-BM (46-92)_Bx_34M_HE_primary myelofibrosis-1

Hemato-74-2-BM_Hemato-BM (46-92)_Bx_74M_HE_primary myelofibrosis-2

Hemato-74-3-BM_Hemato-BM (46-92)_Au_51F_HE/silver/macro_primary myelofibrosis-3

Hemato-75-1-BM_Hemato-BM (46-92)_Bx_63F_HE_essential thrombocythemia-1

Hemato-75-2-1-BM_Hemato-BM (46-92)_Bx_87F_HE_essential thrombocythemia-2-1

Hemato-75-2-2-BM_Hemato-BM (46-92)_Bx_87F_silver_essential thrombocythemia-2-2

Hemato-75-2-3-BM_Hemato-BM (46-92)_Bx_87F_IHC (CD61)_essential thrombocythemia-2-3

Hemato-76-BM_Hemato-BM (46-92)_Bx_63F_HE_chronic myeloid leukemia (CML)

Hemato-77-1-BM_Hemato-BM (46-92)_Asp_74F_HE_chronic myeloid leukemia, lymphoid crisis

Hemato-77-2-BM_Hemato-BM (46-92)_Au_56M_HE_chronic myeloid leukemia, megakaryoblastic crisis

Hemato-77-3-BM_Hemato-BM (46-92)_Asp_50'sM_HE/Giemsa/pox/IHC_chronic myeloid leukemia, myeloid crisis

Hemato-78-1-BM_Hemato-BM (46-92)_Au_74M_HE_chronic neutrophilic leukemia-1

Hemato-78-2-BM_Hemato-BM (46-92)_Au_74M_HE_chronic neutrophilic leukemia-2

Hemato-79-BM_Hemato-BM (46-92)_Asp/Bx_-_Giemsa/HE_myeloproliferative disorders in May-Giemsa smears and HE preparations

Hemato-80-1-1-BM_Hemato-BM (46-92)_Asp_70M_HE_multiple myeloma, non-secretory-1

Hemato-80-1-2-BM_Hemato-BM (46-92)_Asp_70M_IHC (CD138)_multiple myeloma, non-secretory-2

Hemato-80-2-BM_Hemato-BM (46-92)_Asp_74F_HE_multiple myeloma, IgA, lambda-type

Hemato-80-3-BM_Hemato-BM (46-92)_Asp_82F_HE_multiple myeloma, flame cell type, IgA, kappa-type

Hemato-80-4-1-BM_Hemato-BM (46-92)_Asp_76F_HE_multiple myeloma producing alpha-chain devoid of light chains-1

Hemato-80-4-2-BM_Hemato-BM (46-92)_Asp_76F_HE/Giemsa/IHC/EM_multiple myeloma producing alpha-chain devoid of light chains-2

Hemato-80-5-BM_Hemato-BM (46-92)_Asp_80F_HE_multiple myeloma, IgG, lambda-type

Hemato-80-6-BM_Hemato-BM (46-92)_Asp_77M_HE_multiple myeloma, IgG, lambda-type, with Russell body formation

Hemato-80-7-BM_Hemato-BM (46-92)_Asp_64M_HE_multiple myeloma, lambda-type, with hyaline cytoplasmic inclusions

Hemato-80-8-BM_Hemato-BM (46-92)_Asp_67M_HE_multiple myeloma, IgG, kappa-type with cryoglobulin deposition

Hemato-80-9-BM_Hemato-BM (46-92)_Au_64M_HE_multiple myeloma, kappa-type with systemic amyloidosis

Hemato-80-10-1-BM_Hemato-BM (46-92)_Au_78M_HE_multiple myeloma, IgD, lambda type-1

Hemato-80-10-2-BM_Hemato-BM (46-92)_Au_78M_IHC (IgD)_multiple myeloma, IgD, lambda type with LCDD-2

Hemato-80-10-3-BM_Hemato-BM (46-92)_Au_78M_IHC (lambda)_multiple myeloma, IgD, lambda type with LCDD-3

Hemato-80-11-1-BM_Hemato-BM (46-92)_Bx_72M_HE_multiple myeloma, IgM, kappa type-1

Hemato-80-11-2-BM_Hemato-BM (46-92)_Bx_72M_IHC (IgM)_multiple myeloma, IgM, kappa type-2

Hemato-80-11-3-BM_Hemato-BM (46-92)_Smear_72M_Giemsa_multiple myeloma, IgM, kappa type-3

Hemato-80-12-BM_Hemato-BM (46-92)_cell block_82F_HE_multiple myeloma, kappa type, with pleural dissemination

Hemato-81-BM_Hemato-BM (46-92)_Asp_47M_HE_plasma cell leukemia, kappa type

Hemato-82-BM_Hemato-BM (46-92)_Asp_65M_HE_Waldenström macroglobulinemia, IgM, kappa-type

Hemato-83-1-BM_Hemato-BM (46-92)_Bx_51M_HE_lymphoplasmacytic lymphoma-1

Hemato-83-2-BM_Hemato-BM (46-92)_Asp_72M_HE_lymphoplasmacytic lymphoma-2

Hemato-83-3-BM_Hemato-BM (46-92)_Asp_74F_HE_lymphoplasmacytic lymphoma, large cell type

Hemato-84-BM_Hemato-BM (46-92)_Asp/Bx/Au_adults_HE/Giemsa/IHC/EM_pathology of plasma cells

Hemato-85-BM_Hemato-BM (46-92)_Asp_71M_HE_mantle cell lymphoma with bone marrow involvement.

Hemato-86-BM_Hemato-BM (46-92)_Bx (rib)_12F_HE_Anaplastic large cell lymphoma (Ki-1 lymphoma)

Hemato-87-BM_Hemato-BM (46-92)_Asp_58F_HE_T-cell lymphoma, large cell type

Hemato-88-BM_Hemato-BM (46-92)_Asp_54M_HE_T-cell lymphoma, hemophagocytic lymphohistiocytosis-type

Hemato-89-1-BM_Hemato-BM (46-92)_Asp_40'sM_HE_NK/T-cell lymphoma-1

Hemato-89-2-BM_Hemato-BM (46-92)_Asp_40'sM_IHC (perforin)_NK/T-cell lymphoma-2

Hemato-90-BM_Hemato-BM (46-92)_Asp_79M_HE_blastic plasmacytoid dendritic cell neoplasm

Hemato-91-BM_Hemato-BM (46-92)_Asp_1moM_HE_Letterer-Siwe disease

Hemato-91-a-BM_Hemato-BM (46-92)_Au_27M_HE/esterase/IHC/EM_systemic mastocytosis with urticaria pigmentosa

Hemato-92-1-1-BM_Hemato-BM (46-92)_Asp_37M_HE_metastatic signet ring cell carcinoma

Hemato-92-1-2-BM_Hemato-BM (46-92)_Au_51F_HE/Giemsa/macro_metastatic signet ring cell carcinoma of the stomach: an autopsy case

Hemato-92-2-BM_Hemato-BM (46-92)_Bx_82M_HE_metastatic prostatic adenocarcinoma

Hemato-92-3-BM_Hemato-BM (46-92)_Bx_78M_HE_metastatic pancreas adenocarcinoma

Hemato-92-4-BM_Hemato-BM (46-92)_Bx_66M_HE_metastatic small cell lung carcinoma

Hemato-92-5-BM_Hemato-BM (46-92)_Bx_3M_HE_metastatic neuroblastoma

Hemato-92-6-BM_Hemato-BM (46-92)_Bx_34M_HE_metastatic malignant mesothelioma of pleura

Hemato-93-LN_Hemato-LN (93-161)_Ex_54F_HE_normal lymph nodes with afferent lymphatics

Hemato-94-1-LN_Hemato-LN (93-161)_Ex_67M_HE_reactive lymphadenopathy-1

Hemato-94-2-LN_Hemato-LN (93-161)_Bx_78F_HE_reactive lymphadenopathy-2

Hemato-94-3-1-LN_Hemato-LN (93-161)_Bx_21M_HE_follicular hyperplasia with IgE deposition in the germinal center-1

Hemato-94-3-2-LN_Hemato-LN (93-161)_Bx_21M_IHC (IgE)_follicular hyperplasia with IgE deposition in the germinal center-2

Hemato-94-4-1-LN_Hemato-LN (93-161)_Bx_adultM_HE_Kimura's disease-1

Hemato-94-4-2-LN_Hemato-LN (93-161)_Bx_adultM_IHC (IgE)_Kimura's disease-2

Hemato-94-5-LN_Hemato-LN (93-161)_Bx_adultF_HE_Russell bodies in germinal centers

Hemato-94-6-1-LN_Hemato-LN (93-161)_Bx_47M_HE_mantle zone hyperplasia-1

Hemato-94-6-2-LN_Hemato-LN (93-161)_Bx_47M_IHC (CD20)_mantle zone hyperplasia-2

Hemato-94-7-LN_Hemato-LN (93-161)_Bx_32F_HE_monocytoid B-cell hyperplasia

Hemato-94-8-LN_Hemato-LN (93-161)_Bx_66F_HE_paracortical hyperplasia

Hemato-94-9-LN_Hemato-LN (93-161)_Bx_54F_HE_medullary hyperplasia

Hemato-94-10-LN_Hemato-LN (93-161)_Bx_85F_HE_sinus histiocytosis

Hemato-94-11-LN_Hemato-LN (93-161)_Bx_38F_HE_hemosiderosis

Hemato-94-12-LN_Hemato-LN (93-161)_Bx_30'sF_HE_lymphadenopathy in SLE

Hemato-94-13-LN_Hemato-LN (93-161)_Bx_adults_HE/lectin_expression of  receptors for Helix pomatia agglutinin on mature T-cells and some B-cells in neuraminidase-treated paraffin sections

Hemato-95-1-LN_Hemato-LN (93-161)_Bx_43F_HE_endosalpingiosis

Hemato-95-2-LN_Hemato-LN (93-161)_Bx_52F_HE_endometriosis

Hemato-95-3-LN_Hemato-LN (93-161)_Bx_46M_HE_ectopic salivary gland

Hemato-96-1-LN_Hemato-LN (93-161)_Bx_50'sF_HE_lymphadenopathy due to pedal lymphangiography

Hemato-96-2-LN_Hemato-LN (93-161)_Bx_40'sM_HE_lipogranulomatous lymphadenopathy

Hemato-97-1-LN_Hemato-LN (93-161)_Ex_10M_HE (LN)_yersiniosis (Yersinia enterocolitica infection)-1

Hemato-97-2-LN_Hemato-LN (93-161)_Rx_10M_HE (colon)_yersiniosis (Yersinia enterocolitica infection)-2

Hemato-98-LN_Hemato-LN (93-161)_Bx_85M_HE_tularemia (Francisella tularensis infection)

Hemato-99-1-LN_Hemato-LN (93-161)_Bx_53F_HE_cat scratch disease (bartonellosis)-1

Hemato-99-2-LN_Hemato-LN (93-161)_Bx_53F_IHC (B. henselae)_cat scratch disease (bartonellosis)-2

Hemato-100-1-LN_Hemato-LN (93-161)_Bx_adult M_HE_syphilitic lymphadenitis-1

Hemato-100-2-LN_Hemato-LN (93-161)_Bx_adult M_IHC (T. pallidum)_syphilitic lymphadenitis-2

Hemato-101-1-LN_Hemato-LN (93-161)_Ex_67F_HE_tuberculous lymphadenitis

Hemato-101-2-LN_Hemato-LN (93-161)_Ex_70M_HE_scrofuloderma with connection with lymph nodal tuberculosis

Hemato-102-1-LN_Hemato-LN (93-161)_Ex_76M_HE_disseminated BCG infection (S/P: BCG intravesical instillation therapy against urinary bladder cancer)-1

Hemato-102-2-LN_Hemato-LN (93-161)_Ex_76M_IHC (BCG)_disseminated BCG infection (S/P: BCG therapy against urinary bladder cancer) -2

Hemato-103-1-LN_Hemato-LN (93-161)_Au_46M_HE_non-tubercuolous mycobacterial infection in CML

Hemato-103-2-LN_Hemato-LN (93-161)_Au_22M_HE_non-tuberculous mycobacteriosis in AIDS

Hemato-104-1-LN_Hemato-LN (93-161)_Au_70'sM_HE_nodal cryptococcosis

Hemato-104-2-LN_Hemato-LN (93-161)_Au_35M_HE_nodal cryptococcosis in AIDS

Hemato-105-1-LN_Hemato-LN (93-161)_Ex_39M_HE_nodal paracoccidioidomycosis in a second-generation Japanese Brazilian-1

Hemato-105-2-LN_Hemato-LN (93-161)_Ex_39M_Grocott_nodal paracoccidioidomycosis in a second-generation Japanese Brazilian-2

Hemato-106-1-LN_Hemato-LN (93-161)_Bx_adult M_HE_North American blastomycosis in a Japanese patient infected in Illinois, USA-1

Hemato-106-2-LN_Hemato-LN (93-161)_Bx_adult M_PAS_North American blastomycosis in a Japanese patient infected in Illinois, USA-2

Hemato-107-1-LN_Hemato-LN (93-161)_Bx_20'sM_HE_measles lymphadenitis-1

Hemato-107-2-LN_Hemato-LN (93-161)_Au_1.5moM_HE_measles lymphadenitis-2

Hemato-108-LN_Hemato-LN (93-161)_Bx_18M_HE_infectious mononucleosis

Hemato-109-1-LN_Hemato-LN (93-161)_Au_20'sM_HE_EBV-associated hemophagocytic syndrome (EB-VAHS), a lethal case-1

Hemato-109-2-LN_Hemato-LN (93-161)_Au_20'sM_ISH (EBER)_EBV-associated hemophagocytic syndrome (EB-VAHS), a lethal case-2

Hemato-110-1-LN_Hemato-LN (93-161)_Au_30'sM_HE_lymphadenopathy in AIDS-1

Hemato-110-2-LN_Hemato-LN (93-161)_Au_30'sM_IHC (HIV-1: p24)_lymphadenopathy in AIDS-2

Hemato-111-LN_Hemato-LN (93-161)_Bx_64M_HE_HTLV-1-associated lymphadenopathy

Hemato-112-1-1-LN_Hemato-LN (93-161)_Bx_40'sM_HE_Toxoplasma lymphadenitis-1

Hemato-112-1-2-LN_Hemato-LN (93-161)_Bx_40'sM_IHC (T. gondii)_Toxoplasma lymphadenitis-2

Hemato-112-2-LN_Hemato-LN (93-161)_Bx_32F_HE_reactive lymphadenopathy, Piringer-Kuchinka type

Hemato-113-1-LN_Hemato-LN (93-161)_Bx_35F_HE_sarcoidosis

Hemato-113-2-LN_Hemato-LN (93-161)_Bx_61F_HE_sarcoidosis with asteroid bodies

Hemato-114-1-LN_Hemato-LN (93-161)_Bx_61F_HE_sarcoid-like reaction with metastatic papillary thyroid carcinoma

Hemato-114-2-LN_Hemato-LN (93-161)_Ex_82F_HE_sarcoid-like reaction in perigastric lymph nodes

Hemato-114-3-LN_Hemato-LN (93-161)_Ex_58F_HE_granulomatous lymphadenitis with keloid-like fibrosis

Hemato-115-LN_Hemato-LN (93-161)_Bx_60'sM_HE_amyloid tumor, IgD (lambda) myeloma

Hemato-116-LN_Hemato-LN (93-161)_Bx_39M_HE_coagulation necrosis with angiitis in SLE

Hemato-117-LN_Hemato-LN (93-161)_Bx_35F_HE_subacute necrotizing lymphadenitis (Kikuchi-Fujimoto)

Hemato-118-LN_Hemato-LN (93-161)_Ex_20'sM_HE_sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman)

Hemato-119-LN_Hemato-LN (93-161)_Bx_63F_HE_progressive transformation of germinal centers

Hemato-120-LN_Hemato-LN (93-161)_Bx_70F_HE_vascular transformation of lymph node sinuses

Hemato-121-1-1-LN_Hemato-LN (93-161)_Bx_14F_HE_Castleman's disease, hyaline vascular type-1

Hemato-121-1-2-LN_Hemato-LN (93-161)_Bx_14F_IHC (fibrinogen)_Castleman's disease, hyaline vascular type-2

Hemato-121-2-LN_Hemato-LN (93-161)_Bx_52F_HE_Castleman's disease, multicentric plasma cell type

Hemato-121-3-LN_Hemato-LN (93-161)_Bx_52F_HE_Castleman's disease, stroma-rich type

Hemato-121-4-LN_Hemato-LN (93-161)_Bx_47F_HE_Castleman's disease manifesting TAFRO syndrome

Hemato-122-1-LN_Hemato-LN (93-161)_Bx_36M_HE_dermatopathic lymphadenopathy-1

Hemato-122-2-1-LN_Hemato-LN (93-161)_Bx_45F_HE_dermatopathic lymphadenopathy-2-1

Hemato-122-2-2-LN_Hemato-LN (93-161)_Bx_45F_Fontana-Masson_dermatopathic lymphadenopathy-2-2

Hemato-123-LN_Hemato-LN (93-161)_Bx_adultF_HE_hemangioma of the lymph node

Hemato-124-LN_Hemato-LN (93-161)_Ex_56F_HE_lymphangiomyomatosis

Hemato-125-LN_Hemato-LN (93-161)_Bx_4M_HE_Hand-Schüller-Christian disease

Hemato-126-LN_Hemato-LN (93-161)_Au_60'sM_HE/macro_Erdheim-Chester disease

Hemato-127-LN_Hemato-LN (93-161)_Bx_58M_HE_methotrexate-associated lymphoproliferative disorder

Hemato-128-1-LN_Hemato-LN (93-161)_Bx_34F_HE_interfollicular CD30-positive immunoblastosis

Hemato-128-2-LN_Hemato-LN (93-161)_Bx_34F_IHC (CD30)_interfollicular CD30-positive immunoblastosis

Hemato-129-1-LN_Hemato-LN (93-161)_Bx_44M_HE_atypical paracortical hyperplasia-1

Hemato-129-2-LN_Hemato-LN (93-161)_Bx_55M_HE_atypical paracortical hyperplasia-2

Hemato-130-1-LN_Hemato-LN (93-161)_Bx_59M_HE_mantle cell lymphoma

Hemato-130-2-LN_Hemato-LN (93-161)_Bx_59M_HE_mantle cell lymphoma with blastoid transformation

Hemato-130-3-LN_Hemato-LN (93-161)_Bx_50'sM_HE/IHC_mantle cell lymphoma, blastoid variant

Hemato-131-1-LN_Hemato-LN (93-161)_Bx_56F_HE_MALT lymphoma with salivary gland components

Hemato-131-2-LN_Hemato-LN (93-161)_Bx_66M_HE_nodal marginal zone lymphoma

Hemato-131-3-LN_Hemato-LN (93-161)_needle Bx_64F_HE_B-cell lymphoma with Russell bodies

Hemato-132-1-LN_Hemato-LN (93-161)_Bx_62M_HE_small B-cell lymphoma

Hemato-132-2-LN_Hemato-LN (93-161)_Bx_63F_HE_small B-cell lymphoma with proliferation centers

Hemato-132-3-LN_Hemato-LN (93-161)_Bx_58M_HE_small B-cell lymphoma with leukemic manifestation

Hemato-133-1-LN_Hemato-LN (93-161)_Bx_64M_HE_follicular lymphoma, G1

Hemato-133-2-LN_Hemato-LN (93-161)_Bx_49F_HE_follicular lymphoma, G2

Hemato-133-3-LN_Hemato-LN (93-161)_Bx_84M_HE_follicular lymphoma, G3A

Hemato-134-1-LN_Hemato-LN (93-161)_Bx_59M_HE_follicular lymphoma (G1) with mantle cell lymphoma

Hemato-134-2-LN_Hemato-LN (93-161)_Bx_59M_HE_follicular lymphoma with diffuse transformation

Hemato-135-1-LN_Hemato-LN (93-161)_Bx_61M_HE_lymphoplasmacytic B-cell lymphoma with macroglobulinemia

Hemato-135-2-LN_Hemato-LN (93-161)_Bx_70F_HE_diffuse large B-cell lymphoma, immunoblastic, IgM(k)-type

Hemato-136-1-LN_Hemato-LN (93-161)_needle Bx_73F_HE_diffuse B-cell lymphoma, Burkitt-like high-grade

Hemato-136-2-LN_Hemato-LN (93-161)_Bx_62M_HE_diffuse large B-cell lymphoma with epithelioid cell reaction

Hemato-136-3-LN_Hemato-LN (93-161)_Bx_63M_HE_diffuse large B-cell lymphoma with eosinophilia

Hemato-136-4-LN_Hemato-LN (93-161)_Bx_20M_HE_primary mediastinal large B-cell lymphoma

Hemato-137-LN_Hemato-LN (93-161)_Bx_60F_HE_diffuse large B-cell lymphoma with bizarre multinucleated cells

Hemato-138-1-LN_Hemato-LN (93-161)_Bx_89M_HE_diffuse large B-cell lymphoma, GCB type

Hemato-138-2-LN_Hemato-LN (93-161)_needle Bx_81F_HE_diffuse large B-cell lymphoma, ABC type

Hemato-138-a-LN_Hemato-LN (93-161)_Bx/Au_39F_HE/ATPase/AcPase_ATPase activity in B-cell lymphoma

Hemato-139-1-1-LN_Hemato-LN (93-161)_Bx_82F_HE_EBV-positive diffuse large B-cell lymphoma-1

Hemato-139-1-2-LN_Hemato-LN (93-161)_Bx_82F_IHC (CD30)_EBV-positive diffuse large B-cell lymphoma-2

Hemato-139-1-3-LN_Hemato-LN (93-161)_Bx_82F_IHC (LMP1)_EBV-positive diffuse large B-cell lymphoma-3

Hemato-139-1-4-LN_Hemato-LN (93-161)_Bx_82F_IHC (EBNA2)_EBV-positive diffuse large B-cell lymphoma-4

Hemato-139-2-1-LN_Hemato-LN (93-161)_Bx_39F_HE_post-transplant EBV-positive B-cell lymphoma-1

Hemato-139-2-2-LN_Hemato-LN (93-161)_Bx_39F_ISH (EBER)_post-transplant EBV-positive B-cell lymphoma-2

Hemato-139-3-1-LN_Hemato-LN (93-161)_Bx_86M_HE (skin)_EBV-positive mucocutaneous ulcer, plasmablastic type-1

Hemato-139-3-2-LN_Hemato-LN (93-161)_Bx_86M_HE/IHC/ISH_EBV-positive mucocutaneous ulcer, plasmablastic type-2

Hemato-139-4-LN_Hemato-LN (93-161)_Ex_84M_HE/IHC/EM_plasmablastic lymphoma of the parietal pleura

Hemato-139-5-LN_Hemato-LN (93-161)_Bx_81M_HE_pyothorax-associated B-cell lymphoma

Hemato-140-1-LN_Hemato-LN (93-161)_cell block_58F_HE_primary effusion lymphoma-1

Hemato-140-2-LN_Hemato-LN (93-161)_cell block_58F_HE_primary effusion lymphoma-2

Hemato-141-1-LN_Hemato-LN (93-161)_Bx_36M_HE_Burkitt lymphoma

Hemato-141-2-1-LN_Hemato-LN (93-161)_Bx_60M_HE_Burkitt lymphoma with nodular architectures-1

Hemato-141-2-2-LN_Hemato-LN (93-161)_Bx_60M_HE/IHC/ISH_Burkitt lymphoma with nodular architectures-2

Hemato-142-1-LN_Hemato-LN (93-161)_Bx_73F_HE_NK cell lymphoma, high-grade-1

Hemato-142-2-LN_Hemato-LN (93-161)_Bx_73F_ISH (EBER)_NK cell lymphoma, high-grade-2

Hemato-142-3-LN_Hemato-LN (93-161)_Bx_73F_IHC (granzyme B)_NK cell lymphoma, high-grade-3

Hemato-143-1-LN_Hemato-LN (93-161)_Bx_65M_HE_angioimmunoblastic T-cell lymphoma-1

Hemato-143-2-LN_Hemato-LN (93-161)_Bx_86M_HE_angioimmunoblastic T-cell lymphoma-2

Hemato-143-3-LN_Hemato-LN (93-161)_Bx_65M_HE_follicular helper T-cell lymphoma

Hemato-144-1-LN_Hemato-LN (93-161)_Bx_14M_HE_lymphoblastic lymphoma

Hemato-144-2-LN_Hemato-LN (93-161)_Bx_21F_HE_lymphoblastic lymphoma with acute myeloid leukemia

Hemato-145-1-LN_Hemato-LN (93-161)_needle Bx_26F_HE_cytotoxic T-cell lymphoma, medium-sized-1

Hemato-145-2-LN_Hemato-LN (93-161)_needle Bx_26F_IHC (CD8)_cytotoxic T-cell lymphoma, medium-sized-2

Hemato-146-1-LN_Hemato-LN (93-161)_Bx_46F_HE_peripheral T-cell lymphoma, medium-sized cell type

Hemato-146-2-LN_Hemato-LN (93-161)_needle Bx_20F_HE_peripheral T-cell lymphoma, large cell type, with eosinophilia

Hemato-147-1-LN_Hemato-LN (93-161)_Bx_84F_HE_CD4-positive peripheral T-cell lymphoma

Hemato-147-2-LN_Hemato-LN (93-161)_Bx_36M_HE_CD4-positive T-cell lymphoma in Sézary syndrome

Hemato-147-3-LN_Hemato-LN (93-161)_Bx_70'sM_HE_pleomorphic T-cell lymphoma

Hemato-148-1-LN_Hemato-LN (93-161)_Bx_82F_HE_adult T-cell lymphoma, pleomorphic type

Hemato-148-2-LN_Hemato-LN (93-161)_Bx_65M_HE_adult T-cell lymphoma with hypercalcemia

Hemato-149-1-1-LN_Hemato-LN (93-161)_Bx_20'sM_HE_anaplastic large cell lymphoma (Ki-1 lymphoma)-1

Hemato-149-1-2-LN_Hemato-LN (93-161)_Bx_20'sM_IHC (CD30)_anaplastic large cell lymphoma (Ki-1 lymphoma)-2

Hemato-149-2-1-LN_Hemato-LN (93-161)_Bx_77M_HE_anaplastic large cell lymphoma (Ki-1 lymphoma) with epithelioid appearance-1

Hemato-149-2-2-LN_Hemato-LN (93-161)_Bx_77M_IHC (keratin-WSS)_anaplastic large cell lymphoma (Ki-1 lymphoma) with epithelioid appearance-2

Hemato-149-3-LN_Hemato-LN (93-161)_Bx_19M_HE_anaplastic large cell lymphoma (Ki-1 lymphoma) with cytokeratin expression-1

Hemato-149-4-LN_Hemato-LN (93-161)_Bx_19M_HE/IHC_anaplastic large cell lymphoma (Ki-1 lymphoma) with cytokeratin expression-2

Hemato-150-1-1-LN_Hemato-LN (93-161)_Bx_58M_HE_Lennert lymphoma-1

Hemato-150-1-2-LN_Hemato-LN (93-161)_Bx_58M_IHC (CD68)_Lennert lymphoma-2

Hemato-150-2-LN_Hemato-LN (93-161)_Bx_61M_HE_Lennert lymphoma with eosinophilia

Hemato-151-1-LN_Hemato-LN (93-161)_Bx_40'sM_HE_Hodgkin lymphoma (MC)-1

Hemato-151-2-LN_Hemato-LN (93-161)_Bx_40'sM_ISH (EBER)_Hodgkin lymphoma (MC)-2

Hemato-151-3-LN_Hemato-LN (93-161)_Bx_40'sM_IHC (CD30)_Hodgkin lymphoma (MC)-3

Hemato-151-4-LN_Hemato-LN (93-161)_Bx_40'sM_IHC (CD15)_Hodgkin lymphoma (MC)-4

Hemato-152-1-LN_Hemato-LN (93-161)_Bx_45M_HE_Hodgkin lymphoma (NLPHL)

Hemato-152-2-LN_Hemato-LN (93-161)_Bx_75F_HE_Hodgkin lymphoma (LR)

Hemato-152-3-LN_Hemato-LN (93-161)_Bx_70M_HE_Hodgkin lymphoma (LR), L&H-rich

Hemato-152-4-LN_Hemato-LN (93-161)_Bx_22F_HE_Hodgkin lymphoma (NS)

Hemato-152-5-LN_Hemato-LN (93-161)_Bx_63M_HE_Hodgkin lymphoma (MC)

Hemato-152-6-1-LN_Hemato-LN (93-161)_Bx_67M_HE_Hodgkin lymphoma (LD)-1

Hemato-152-6-2-LN_Hemato-LN (93-161)_Bx_67M_IHC (CD30)_Hodgkin lymphoma (LD)-2

Hemato-152-7-LN_Hemato-LN (93-161)_Au_adults_HE/ISH/IHC/macro_reactivities of EBER and CD15 in Hodgkin’s lymphomas autopsied by Dr. Thomas Hodgkin 170 years ago

Hemato-152-8-LN_Hemato-LN (93-161)_Bx_adults_HE/ISH/IHC/macro_Hodgkin’s lymphomas: marker expression

Hemato-153-1-LN_Hemato-LN (93-161)_Bx_19M_HE_Hodgkin-like B-cell lymphoma-1

Hemato-153-2-LN_Hemato-LN (93-161)_Bx_19M_IHC (CD20)_Hodgkin-like B-cell lymphoma-2

Hemato-153-3-LN_Hemato-LN (93-161)_Bx_19M_IHC (CD30)_Hodgkin-like B-cell lymphoma-3

Hemato-153-4-LN_Hemato-LN (93-161)_Bx_19M_HE/IHC_Hodgkin-like B-cell lymphoma (large B-cell lymphoma with Hodgkin's features)

Hemato-154-1-LN_Hemato-LN (93-161)_Bx_81F_HE_methotrexate-induced Hodgkin-like B-cell lymphoma-1

Hemato-154-2-LN_Hemato-LN (93-161)_Bx_81F_IHC (CD20)_methotrexate-induced Hodgkin-like B-cell lymphoma-2

Hemato-154-3-LN_Hemato-LN (93-161)_Bx_81F_IHC (CD30)_methotrexate-induced Hodgkin-like B-cell lymphoma-3

Hemato-155-1-LN_Hemato-LN (93-161)_Bx_69M_HE_follicular dendritic cell sarcoma-1

Hemato-155-2-LN_Hemato-LN (93-161)_Bx_69M_IHC (CD21)_follicular dendritic cell sarcoma-2

Hemato-156-LN_Hemato-LN (93-161)_Bx_50F_HE_malignant fibroblastic reticulum cell tumor

Hemato-157-LN_Hemato-LN (93-161)_Bx_51M_HE_histiocytic sarcoma (malignant lymphoma, true histiocytic)

Hemato-158-1-1-LN_Hemato-LN (93-161)_Bx_43M_HE_CML, myeloid blast crisis-1

Hemato-158-1-2-LN_Hemato-LN (93-161)_Bx_43M_IHC (myeloperoxidase)_CML, myeloid blast crisis-2

Hemato-158-2-LN_Hemato-LN (93-161)_Bx_55M_HE_CML, lymphoid blast crisis

Hemato-159-LN_Hemato-LN (93-161)_Bx/Au_adults_HE/macro_the incidence of hematological malignancies in Japan

Hemato-160-1-LN_Hemato-LN (93-161)_Bx_88M_HE_metastatic papillary thyroid carcinoma with Hodgkin lymphoma (MC)

Hemato-160-2-LN_Hemato-LN (93-161)_Bx_50'sM_HE_metastatic medullary thyroid carcinoma

Hemato-160-3-LN_Hemato-LN (93-161)_Bx_89F_HE_metastatic signet ring cell carcinoma

Hemato-160-4-LN_Hemato-LN (93-161)_Bx_80F_HE_metastatic colonic adenocarcinoma

Hemato-160-5-LN_Hemato-LN (93-161)_Bx_29F_HE_micrometastasis of breast cancer

Hemato-160-6-LN_Hemato-LN (93-161)_Bx_34F_HE_metastatic breast carcinoma, pure HER2-type

Hemato-160-7-LN_Hemato-LN (93-161)_Bx_28F_HE_micrometastasis of serous papillary adenocarcinoma of the ovary

Hemato-160-8-LN_Hemato-LN (93-161)_Bx_63M_HE_metastatic prostatic adenocarcinoma

Hemato-160-9-LN_Hemato-LN (93-161)_Bx_71M_HE_metastatic laryngeal squamous cell carcinoma

Hemato-160-10-LN_Hemato-LN (93-161)_Bx_50'sM_HE_metastatic carcinoid tumor

Hemato-161-1-1-LN_Hemato-LN (93-161)_Bx_34M_HE_metastatic amelanotic melanoma-1

Hemato-161-1-2-LN_Hemato-LN (93-161)_Bx_34M_IHC (S-100)_metastatic amelanotic melanoma-2

Hemato-161-1-3-LN_Hemato-LN (93-161)_Bx_34M_HE/Grimelius/IHC_metastatic amelanotic melanoma in the lymph node

Hemato-161-2-LN_Hemato-LN (93-161)_Bx_3M_HE_metastatic neuroblastoma

​